Task: Answer the multiple-choice question.
Question: Which compound exhibits a 8.024\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) Cc1nn(Cc2ccccc2Cl)c2sc(C(=O)NC(C)(C)C)cc12
b.) Cc1cc(NC(=O)Cn2nnc(-c3ccccc3NC(=O)c3ccccc3F)n2)no1
c.) CCN(CC)CCCNC(CC(=O)Nc1cccc([N+](=O)[O-])c1)C(=O)O
d.) CCOC(=O)c1cc[nH]c1CC(=O)NC
e.) CC(C)=NNC(=O)CN1C(=O)NC2NC(=O)NC21
Answer: e. CC(C)=NNC(=O)CN1C(=O)NC2NC(=O)NC21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)=NNC(=O)CN1C(=O)NC2NC(=O)NC21
CC(C)=NNC(=O)CN1C(=O)NC2NC(=O)NC21
2-(2,5-dioxo-3,3a,6,6a-tetrahydro-1H-imidazo[4,5-d]imidazol-4-yl)-N-(propan-2-ylideneamino)acetamide